TY  - GEN
AU  - Nicolino,Marc
AU  - Byrne,Barry
AU  - Wraith,J Edmund
AU  - Leslie,Nancy
AU  - Mandel,Hanna
AU  - Freyer,David R
AU  - Arnold,Georgianne L
AU  - Pivnick,Eniko K
AU  - Ottinger,C J
AU  - Robinson,Peter H
AU  - Loo,John-Charles A
AU  - Smitka,Martin
AU  - Jardine,Philip
AU  - Tatò,Luciano
AU  - Chabrol,Brigitte
AU  - McCandless,Shawn
AU  - Kimura,Shigemi
AU  - Mehta,L
AU  - Bali,Deeksha
AU  - Skrinar,Alison
AU  - Morgan,Claire
AU  - Rangachari,Lakshmi
AU  - Corzo,Deya
AU  - Kishnani,Priya S
TI  - Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
SN  - 1530-0366
PY  - 2009///0925
KW  - Body Height
KW  - Body Weight
KW  - Child, Preschool
KW  - Cough
KW  - chemically induced
KW  - Echocardiography
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Glycogen
KW  - metabolism
KW  - Glycogen Storage Disease Type II
KW  - drug therapy
KW  - Humans
KW  - Immunoglobulin G
KW  - blood
KW  - Infant
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Muscle, Skeletal
KW  - drug effects
KW  - Skin Diseases
KW  - Time Factors
KW  - Treatment Outcome
KW  - alpha-Glucosidases
KW  - adverse effects
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/GIM.0b013e31819d0996
ER  -